Fluoxetine Hcl

Verify with FDA CVM →

360 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
360
Total Reports
15
Deaths Reported
420.0%
Death Rate

Active Ingredients

Fluoxetine Hcl

Administration Routes

OralUnknownOphthalmic

Species Affected

Dog 334
Cat 19
Human 7

Most Affected Breeds

Retriever - Labrador 37
Pug 14
Shepherd Dog - German 13
Crossbred Canine/dog 13
Terrier - Bull - American Pit 13
Boxer (German Boxer) 11
Beagle 10
Domestic Shorthair 10
Retriever - Golden 8
Unknown 7

Most Reported Reactions

Vomiting 69
Lethargy (see also Central nervous system depression in 'Neurological') 42
Emesis 38
Lack of efficacy - NOS 31
Diarrhoea 26
Behavioural disorder NOS 24
Seizure NOS 24
Anxiety 22
Decreased appetite 17
Weight loss 15
Other abnormal test result NOS 15
Panting 14

Outcome Breakdown

Ongoing
131 (36.3%)
Recovered/Normal
124 (34.3%)
Outcome Unknown
83 (23.0%)
Euthanized
12 (3.3%)
Recovered with Sequela
8 (2.2%)
Died
3 (0.8%)

Data Summary

Metric Value
Total adverse event reports 360
Reports involving death 15
Case-fatality rate (reported events) 420.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Fluoxetine Hcl Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 360 adverse event reports referencing Fluoxetine Hcl, including 15 reports in which the animal died — a 420.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Fluoxetine Hcl. Reported administration routes include Oral, Unknown, Ophthalmic. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Fluoxetine Hcl reports are Dog (334 reports), Cat (19 reports), Human (7 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (37), Pug (14), Shepherd Dog - German (13) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Fluoxetine Hcl are Vomiting (69), Lethargy (see also Central nervous system depression in 'Neurological') (42), Emesis (38), Lack of efficacy - NOS (31). Of the 361 reports with a coded outcome, Ongoing is the leading category at 36.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Fluoxetine Hcl.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial